By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RespireRx (Formerly Known As Cortex Pharmaceuticals, Inc.) 

15241 Barranca Parkway

Irvine  California  92718  U.S.A.
Phone: 949-727-3157 Fax: 949-727-3657


SEARCH JOBS


Industry
Biotechnology






Company News
RespireRx (RSRX) Announces Participation SLEEP 2017 In Boston, MA 6/7/2017 6:46:17 AM
RespireRx (RSRX) Announces Positive Results From Phase 2B PACE Study Conducted By The University of Illinois Dronabinol Reduces Symptoms Of Obstructive Sleep Apnea 12/27/2016 7:37:45 AM
RespireRx (RSRX) Announces Data For CX1739 Clinical Study In Opioid Induced Respiratory Depression 12/15/2016 12:51:46 PM
RespireRx (RSRX) Files September 30, 2016 Quarterly Report On Form 10-Q 11/16/2016 12:18:29 PM
RespireRx (RSRX) Retracts Efficacy Data In September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis Of Safety And Efficacy Data From Duke University Phase 2A Clinicial Trial Of CX 1739 10/4/2016 10:27:39 AM
UPDATE - RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/13/2016 11:34:20 AM
RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/12/2016 12:23:06 PM
RespireRx (RSRX) To Present At Rodman & Renshaw18th Annual Global Investment Conference On September 12, 2016 9/9/2016 11:05:29 AM
RespireRx (RSRX) Announces 1-for-325 Reverse Stock Split 9/2/2016 9:49:56 AM
RespireRx (RSRX) Files June 30, 2016 Quarterly Report On Form 10-Q 8/16/2016 7:18:59 AM
12345678910...
//-->